CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 424B3 Offering Prospectus
- S-1/A Offering Registration Statement
- S-1 Offering Registration Statement
- 8-K Event Material agreement
- REGDEX Other REGDEX
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Unregistered share sale
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 62 of 64 · 1,274 filings